No Data
Express News | Eagle Announces Update on Delisting From Nasdaq and SEC Deregistration
Express News | Eagle Pharmaceuticals-Expects to Conclude One or More Material Weaknesses Related to the Matters Existed in Internal Control Over Financial Reporting
Express News | Eagle Pharmaceuticals Inc - Files for Non Timely 10-Q With U.S. SEC
Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer
Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
Union Square Park Capital Management's Strategic Acquisition of Eagle Pharmaceuticals Shares
No Data
No Data